Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy?
Encouraging Results of a Preliminary Study Evidence Based Complementary and Alternative Medicine, 2007 Oct 29. In a study involving 38 thalassemic patients receiving hydroxyurea (HU) therapy for varying periods of time, administration of appropriately selected homeopathic medicine for three months was found to be associated with significant decreases in serum ferritin and increases in serum fetal hemoglobin. Furthermore, a significant decrease in the size of the spleen was found in most of the patients with splenomegaly (enlarged spleen). Moreover, an increased gap between transfusions was found in most patients who received the homeopathic medicine, in addition to hydroxyurea therapy. M. Frass, et.al Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit Ludwig Boltzmann Institute for Homeopathy, 2005. Seventy patients with severe sepsis received homeopathic treatment (n = 35) or placebo (n = 35).